Peter Tugwell
Overview
Explore the profile of Peter Tugwell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
674
Citations
27922
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Beaton D, Boers M, Bingham C, Maxwell L, Conaghan P, Grosskleg S, et al.
Semin Arthritis Rheum
. 2025 Mar;
72:152664.
PMID: 40086155
Background: Literature reviews of measurement properties of an outcome measurement instrument are fast becoming the evidence base for making decisions about the suitability of the instrument for a given application....
2.
Jones C, Hamilton C, Tugwell P, Grosskleg S, Hofstetter C, Horgan B, et al.
Semin Arthritis Rheum
. 2025 Mar;
72:152704.
PMID: 40054384
Background: OMERACT (Outcome Measures in Rheumatology) is an international initiative focused on improving outcome measurement in rheumatology research, fostering collaboration among PRPs, clinicians, and researchers to develop Core Outcome Sets....
3.
Petkovic J, Magwood O, Concannon T, Akl E, Khabsa J, Lytvyn L, et al.
J Clin Epidemiol
. 2025 Feb;
:111727.
PMID: 39971165
Objectives: Better engagement of diverse groups of interest-holders in the development of health guidelines has been proposed to improve their usefulness, implementability, and acceptability. Guidelines shape clinical- or public-health practice...
4.
Sofi-Mahmudi A, Stojanova J, Vounzoulaki E, Tomlinson E, Pizarro A, Khademioore S, et al.
J Clin Epidemiol
. 2025 Feb;
181:111719.
PMID: 39947447
Objectives: The aim of this study was to examine the distribution of country, region, language, and gender diversity in the authorship of Cochrane reviews and compare it to non-Cochrane systematic...
5.
Maltez N, Wang M, Wells G, Tugwell P, Baron M, Marjanovic Z, et al.
Transplant Cell Ther
. 2025 Feb;
PMID: 39938806
Systemic sclerosis (SSc) is a severe, progressive disease with limited treatment options. Autologous hematopoietic stem cell transplantation (AHSCT) has been shown to be an effective treatment for rapidly progressive SSc....
6.
Wells G, Hsieh S, Peterson J, Zheng C, Kelly S, Shea B, et al.
Cochrane Database Syst Rev
. 2025 Jan;
1:CD001155.
PMID: 39868546
Rationale: Osteoporosis is an abnormal reduction in bone mass and bone deterioration, leading to increased fracture risk. Alendronate belongs to the bisphosphonate class of drugs, which inhibit bone resorption by...
7.
Saadat P, Bansback N, Falahee M, Hiligsmann M, Tugwell P, Buchbinder R, et al.
BMJ Open
. 2025 Jan;
15(1):e088267.
PMID: 39819933
Introduction: The pharmacological management of inflammatory arthritis often requires choices that involve trade-offs between benefits, risks and other attributes such as administration route, frequency and cost. This living systematic review...
8.
Petkovic J, Riddle A, Lytvyn L, Khabsa J, Akl E, Welch V, et al.
Campbell Syst Rev
. 2024 Nov;
20(4):e70006.
PMID: 39588485
Background: Health guideline developers engage with interested people and groups to ensure that guidelines and their recommendations are relevant and useful to those who will be affected by them. These...
9.
Karran E, Cashin A, Barker T, Boyd M, Chiarotto A, Mohabir V, et al.
Br J Anaesth
. 2024 Nov;
134(1):235-237.
PMID: 39505590
No abstract available.
10.
Kawano-Dourado L, Kristianslund E, Zeraatkar D, Jani M, Makharia G, Hazlewood G, et al.
BMJ
. 2024 Oct;
387:e079830.
PMID: 39467592
Clinical Question: In adult patients with inflammatory bowel disease, inflammatory arthritis (rheumatoid arthritis, spondyloarthritis, psoriatic arthritis), or psoriasis taking biologic drugs, does proactive therapeutic drug monitoring (TDM) improve outcomes as...